Abstract
Background Modern immuno-oncology has revolutionized cancer therapy in recent years. Objective This article provides an overview of current treatment options. Material and methods Review of the current study situation. Results In oncology immune checkpoint inhibitors (ICPi) in monotherapy or also in combination with other drugs have become the standard of care in many tumor entities. In the ...
Abstract
Background Modern immuno-oncology has revolutionized cancer therapy in recent years. Objective This article provides an overview of current treatment options. Material and methods Review of the current study situation. Results In oncology immune checkpoint inhibitors (ICPi) in monotherapy or also in combination with other drugs have become the standard of care in many tumor entities. In the treatment of hematological neoplasms chimeric antigen receptor (CAR) T-cells and bispecific antibodies have shown impressive response rates. Tumor vaccination represents another treatment option with high potential, but has not yet achieved broad clinical application. Conclusion Immuno-oncology with diverse approaches has become the current standard of care in cancer treatment.
Altmetric